Skip to main content

Assessment of Financial Difficulty in Participants With Chronic Lymphocytic Leukemia and Multiple Myeloma (A231602CD)

Assessing Financial Difficulty in Patients With Blood Cancers

Overview

Overview

This trial studies financial difficulty in participants with chronic lymphocytic leukemia and multiple myeloma. Assessment of financial difficulty may help to better understand the financial impact of cancer and come up with ways to help participants avoid financial problems during treatment.

Key Inclusion Criteria

Key Inclusion Criteria

For a patient to be eligible for participation in this study, all of the following criteria must apply.

  • Patients must have current diagnosis of chronic lymphocytic leukemia (CLL) or multiple myeloma (MM)
  • Patients' medical records must be available to the registering institution
  • Eligible patients must have been prescribed drug-based anticancer therapy, whether administered orally or by infusion, within the prior 12 months. Specifically, eligible patients are those who:
    • Are presently being treated with infused or orally-administered anticancer therapy, OR
    • Completed infused or orally-administered anti-cancer therapy in the past 12 months, OR
    • Were prescribed infused or orally-administered anticancer therapy within the prior 12 months yet chose to forego treatment
  • Not currently enrolled in a clinical trial in which drug is supplied by the study
  • Patients with psychiatric illness or other mental impairment that would preclude their ability to give informed consent or to respond to the telephone survey are not eligible
  • Patients must be able to read and comprehend English or Spanish
Learn More

Learn More

To learn more, visit ClinicalTrials.Gov

Study Type

Observational

Principal Investigator(s)

James D. Bearden III, MD

Contact Us

Contact Us

To participate in this study, please contact Kelsey Hitchins at
864-560-1046